Founded in early 2015, Pharma Business Partners (PBP) is a strategy consulting and market research company that specializes in the Middle Eastern and African markets while having global capabilities. We work with clients in the public and private sectors to help them identify opportunities, address challenges, understand market complexities and devise practical solutions. Our knowledge, experience and networks enable us to comprehensively investigate the pharmaceutical and healthcare sector and provide relevant insights to our clients.
The MEA market has historically lagged behind the US and EU markets. However, with increasing pressure on budgets in developed markets, MEA has emerged as a rising potential for future healthcare growth and investments. This growth prompted my move to Dubai from London, and is how the Pharma Business Partners journey began.
The dynamics in the region are consistently changing, with the introduction of mandatory health insurance in the UAE, to the use of health economics tools in Egypt, the region is fast evolving to catch up with more developed markets.
Given this evolving landscape, the services market has had to play catch up and cater to the needs of the healthcare and pharmaceutical industries.
Whilst numerous firms have supported consulting and research engagements globally, I saw an opportunity to build a firm based on having a true understanding of the local market dynamics, where formulary strategies for both global and regional firms would drive the business.
Our clients come in all shapes and sizes – from global pharma companies, to local healthcare based charities and hospitals, where we have consistently been able to add value and drive growth. Our aim is to continue to drive healthcare and pharmaceutical access in the region, and to provide support to these industries that serve patients when they need it the most.